XML 53 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2014
Jun. 30, 2013
CURRENT ASSETS:    
Cash and cash equivalents $ 4,493 $ 9,007
Short-term bank deposits 19,451 31,449
Restricted cash and restricted short-term deposits 4,914 316
Marketable securities 29,961 13,441
Account receivable from OCS 2,263 273
Other current assets 905 599
Total current assets 61,987 55,085
LONG-TERM ASSETS:    
Long-term deposits and restricted deposits 304 421
Severance pay fund 901 905
Property and equipment, net 10,823 11,866
Other long term assets 8 39
Total long-term assets 12,036 13,231
Total assets 74,023 68,316
CURRENT LIABILITIES    
Trade payables 3,465 2,837
Accrued expenses 915 1,040
Deferred revenues 379 379
Advance payment from United Therapeutics 247 393
Other accounts payable 2,391 1,272
Total current liabilities 7,397 5,921
LONG-TERM LIABILITIES    
Deferred revenues 2,847 3,226
Accrued severance pay 1,068 1,023
Other long-term liabilities 588 680
Total long-term liabilities 4,503 4,929
COMMITMENTS AND CONTINGENCIES      
STOCKHOLDERS' EQUITY    
Share capital: Common stock $0.00001 par value: Authorized: 200,000,000 shares Issued and outstanding: 68,601,452 shares as of June 30, 2014, 59,196,617 shares as of June 30, 2013;      
Additional paid-in capital 172,998 144,109
Accumulated deficit (113,834) (86,902)
Other comprehensive income 2,959 259
Total stockholders' equity 62,123 57,466
Total liabilities and stockholders' equity $ 74,023 $ 68,316